Showing results (151-160 of 183) with videos related to
Sort By:
Pageof 19
Genes & Cancer|June 9, 2022
Using quantitative immunohistochemistry in patients at high risk for hepatocellular cancerSobia Zaidi, Richard Amdur, Xiyan Xiang, et al.Science (New York, N.Y.)|September 28, 2023
In Science JournalsKip Hodges, Ian S Osborne, Daniela Neuhofer, et al.Science (New York, N.Y.)|April 6, 2023
In Science JournalsCourtney S Malo, Priscilla N Kelly, Yury Suleymanov, et al.Multiple Sclerosis and Related Disorders|March 17, 2023
Exploratory clinical efficacy and patient-reported outcomes from NOVA: A randomized controlled study of intravenous natalizumab 6-week dosing versus continued 4-week dosing for relapsing-remitting multiple sclerosisLana Zhovtis Ryerson, John F Foley, Gilles Defer, et al.Science (New York, N.Y.)|January 26, 2023
In Science JournalsKeith T Smith, Dorothy L Hallberg, Michael A Funk, et al.Science (New York, N.Y.)|January 18, 2024
In Science JournalsBrent Grocholski, Yury Suleymanov, Bianca Lopez, et al.The Lancet. Neurology|April 28, 2022
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trialJohn F Foley, Gilles Defer, Lana Zhovtis Ryerson, et al.Science (New York, N.Y.)|October 26, 2023
In Science JournalsIan S Osborne, Madeleine Seale, John F Foley, et al.JCI Insight|December 20, 2019
Secretome profiling identifies neuron-derived neurotrophic factor as a tumor-suppressive factor in lung cancerYa Zhang, Xuefeng Wu, Yan Kai, et al.Science (New York, N.Y.)|March 10, 2022
In Science JournalsBrent Grocholski, Stella M Hurtley, Kip Hodges, et al.Pageof 19